Not recruitingISRCTN79447606
Evaluating the safety and efficacy of PM011 as an antidepressant for patients with mild to moderate depression
Research studyAges 18+South Korea
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.
- Listed locations
- South Korea
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Purimed (South Korea)
- Sponsor type
- Unknown or unclear
- Study type
- Other
- Intervention type
- Other / unclear
- Locations
- South Korea
- Age range
- Over 18 Years
- Official registry ID
- ISRCTN79447606
- Official title
Show the full official title
Evaluating the safety and efficacy of PM011 as an antidepressant for patients with mild to moderate depression
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
South Korea
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Purimed (South Korea).
Who can participate?
This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as not recruiting.
